Physician profile
Jorge M Ramirez
NPI 1679589899
$6,851.58
in general payments reported to CMS, 2019-2025
43 companies · $2,409 in 2025
The $2,409 reported for 2025 was more than what 86% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,952 · 2020: $495 · 2021: $217 · 2022: $168 · 2023: $726 · 2024: $885 · 2025: $2,409.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,904 · Education: $116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,903.62 |
| Education | $116.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aop Health US, LLC | $1,055.25 | 2025 | Rapiblyk |
| Amgen INC. | $624.51 | 2019-2025 | Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $475.56 | 2019-2025 | Jardiance |
| Medtronic, INC. | $466.65 | 2022-2025 | Linq II, Micra |
| Pfizer INC. | $407.57 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $362.68 | 2019-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $325.51 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $318.64 | 2019-2024 | Xarelto |
| Medtronic Vascular, INC. | $254.45 | 2019 | |
| Novo Nordisk INC | $232.13 | 2023-2025 | Wegovy, Ozempic |
| Astrazeneca Pharmaceuticals Lp | $213.67 | 2019-2024 | Brilinta |
| Heartflow, INC. | $186.98 | 2024-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $184.55 | 2019-2025 | Lifevest |
| Abiomed | $169.78 | 2021-2024 | |
| Amarin Pharma, INC. | $157.85 | 2019-2020 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jorge Ramirez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.